A Biodegradable, Porous, Thermally Responsive Injectable Hydrogel as Soft Tissue Defect Filler

A novel injectable hydrogel system is designed for soft tissue repair and reconstruction. It features a biodegradable, thermally responsive polymer synthesized from NIPAAm, VP, and MAPLA in an 80:10:10 ratio, which remains liquid at low temperatures and rapidly gels at 37°C. The formulation incorporates extracellular matrix material extracted from decellularized porcine bladder, maintaining bioactive cues that promote healing. Additionally, biocompatible mannitol particles function as porogens, dissolving after injection to form a porous structure ideal for cell infiltration and integration.

Description

This technology is distinguished by its multi-component approach that combines rapid in situ gelation with controlled, temporary porosity and balanced degradation. The reverse-gelling polymer enables minimally invasive delivery and immediate shape conformation, while the ECM enhances the natural regenerative response. The strategic use of transient porogens ensures a well-organized pore network, facilitating vascularization and improved cellular migration. Extensive in vivo evaluations have confirmed its capacity to drive favorable tissue regeneration, positioning it as a transformative approach in regenerative medicine.

Applications

- Injectable soft tissue repair
- Adipose tissue regeneration scaffold
- Minimally invasive reconstruction
- Regenerative wound healing implant

Advantages

- Minimally invasive injectable delivery for easy application.
- Rapid in situ gelation at body temperature, enabling immediate scaffold formation.
- Controlled porous architecture from mannitol porogens that enhances cell infiltration and tissue integration.
- Enhanced healing response through the inclusion of bioactive ECM material.
- Multiple degradation mechanisms that allow for optimal tissue remodeling and absorption.
- Mechanical properties tailored to mimic natural soft tissue, supporting functional regeneration.
- Demonstrated efficacy in reducing inflammation and promoting favorable macrophage polarization.

IP Status

https://patents.google.com/patent/US20220387670A1

Quick Facts:
Reference Number
04040
Technology Type
Medical Device
Technology Subtype
Implantable Medical Device
Tags
BiomaterialRegenerative medicineTissue engineering
Lead Inventor
William Wagner
Department
Bioengineering
All Tech Innovators
Stephen Francis Badylak DVM, PhD, MDHong Bin JiangHideyoshi SatoWilliam R. Wagner PhDYang Zhu
Date Submitted
2016-10-04
Collections
Regenerative Medicine